Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 50Burkitt Lymphoma 28Leukemia, Biphenotypic, Acute 15Leukemia, Myeloid, Acute 13Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 10Leukemia 10Myelodysplastic Syndromes 9Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 7Osteosarcoma 6Lymphoma 6Leukemia, Myeloid, Accelerated Phase 6Blast Crisis 6Lymphoma, Non-Hodgkin 5Lymphoma, Mantle-Cell 5Lymphoma, Large B-Cell, Diffuse 5Graft vs Host Disease 5Medulloblastoma 4Down Syndrome 4Urinary Bladder Neoplasms 3Recurrence 3Primary Myelofibrosis 3Neoplasm Metastasis 3Myeloproliferative Disorders 3Leukemia, Myelomonocytic, Juvenile 3Hematologic Neoplasms 3Head and Neck Neoplasms 3Blastic Plasmacytoid Dendritic Cell Neoplasm 3Thrombocythemia, Essential 2Rhabdoid Tumor 2Polycythemia Vera 2

Interventions

Methylprednisolone 3Social Determinants of Health 2trastuzumab deruxtecan 1sacituzumab govitecan 1pegaspargase 1Vincristine 1Temozolomide 1Radiotherapy 1Prednisone 1Prednisolone 1Pharmaceutical Services 1Methylprednisolone Hemisuccinate 1Methotrexate 1Mercaptopurine 1Leucovorin 1Irinotecan 1Infliximab 1Hydrocortisone 1Fecal Microbiota Transplantation 1Etoposide 1Drug Therapy 1Doxorubicin 1Dexrazoxane 1Dexamethasone 1Cytarabine 1Cyclophosphamide 1Cefixime 1CTLA-4 Antigen 1Asparaginase 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Drug-Related Side Effects and Adverse Reactions × Methotrexate × 1 year × Clear all
NCT00400946 2026-02-13

05-001: Treatment of Acute Lymphoblastic Leukemia in Children

Dana-Farber Cancer Institute

Phase 3 Completed
800 enrolled 22 charts
LymphoidOther hematologic neoplasm

Leukemia, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Drug-Related Side Effects and Adverse Reactions

Data powered by HemOnc (CC BY 4.0) Colophon âš¡